Cytokines, Graves' disease, and thyroid-associated ophthalmopathy

被引:97
作者
Gianoukakis, Andrew G. [1 ,2 ]
Khadavi, Nicole [2 ]
Smith, Terry J. [1 ,2 ,3 ]
机构
[1] Harbor UCLA Med Ctr, Div Endocrinol & Metab, Torrance, CA 90502 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[3] Harbor UCLA Med Ctr, Div Mol Med, Torrance, CA 90502 USA
关键词
D O I
10.1089/thy.2007.0405
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Graves' disease, an autoimmune process associated with thyroid dysfunction, can also manifest as remodeling of orbital connective tissue. Affected tissues exhibit immune responses that appear to be orchestrated by resident cells and those recruited from the bone marrow through their expression and release of cytokines and surface display of cytokine receptors. Cytokines are small molecules produced by many types of cells, including those of the "professional'' immune system. Aberrant cytokine expression appears to play an important role in the pathogenesis of many human diseases, including thyroid autoimmunity. The skewed pattern of cytokine expression in the thyroid, including the T helper cell bias, may condition the response to apoptotic signals and determine the characteristics of an autoimmune reaction. Furthermore, chemoattractant cytokines, including IL16, RANTES, and CXCL10, elaborated by resident cells in the thyroid and orbit may provoke mononuclear cell infiltration. Other cytokines may drive cell activation and tissue remodeling. Thus cytokines and the signaling pathways they activate represent attractive therapeutic targets. Interruption of these might alter the natural course of Graves' disease and its orbital manifestations.
引用
收藏
页码:953 / 958
页数:6
相关论文
共 72 条
[1]   Cytokines and thyroid function [J].
Ajjan, RA ;
Watson, PF ;
Weetman, AP .
ADVANCES IN NEUROIMMUNOLOGY, 1996, 6 (04) :359-386
[2]   Cytokines in thyroid autoimmunity [J].
Ajjan, RA ;
Weetman, AP .
AUTOIMMUNITY, 2003, 36 (6-7) :351-359
[3]   The sodium iodide symporter gene and its regulation by cytokines found in autoimmmunity [J].
Ajjan, RA ;
Watson, PF ;
Findlay, C ;
Metcalfe, RA ;
Crisp, M ;
Ludgate, M ;
Weetman, AP .
JOURNAL OF ENDOCRINOLOGY, 1998, 158 (03) :351-358
[4]   Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process [J].
Antonelli, A ;
Fallahi, P ;
Rotondi, M ;
Ferrari, SM ;
Romagnani, P ;
Grosso, M ;
Ferrannini, E ;
Serio, M .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 154 (05) :651-658
[5]   Interferon-γ-inducible α-chemokine CXCL10 involvement in Graves' ophthalmopathy:: Modulation by peroxisome proliferator-activated receptor-γ agonists [J].
Antonelli, A ;
Rotondi, M ;
Ferrari, SM ;
Fallahi, P ;
Romagnani, P ;
Franceschini, SS ;
Serio, M ;
Ferrannini, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (02) :614-620
[6]   Expression of cytokines in the thyroid: Thyrocytes as potential cytokine producers [J].
Aust, G ;
Scherbaum, WA .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1996, 104 :64-67
[7]   Immunohistochemical analysis of orbital connective tissue specimens of patients with active graves ophthalmopathy [J].
Avunduk, AM ;
Avunduk, MC ;
Pazarli, H ;
Oguz, V ;
Varnell, ED ;
Kaufman, HE ;
Aksoy, F .
CURRENT EYE RESEARCH, 2005, 30 (08) :631-638
[8]   Interferon-α-induced hyperthyroidism:: a three-stage evolution from silent thyroiditis towards Graves' disease [J].
Bohbot, NL ;
Young, J ;
Orgiazzi, J ;
Buffet, C ;
Francois, M ;
Bernard-Chabert, B ;
Lukas-Croisier, C ;
Delemer, B .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 154 (03) :367-372
[9]   Activation of human orbital fibroblasts through CD40 engagement results in a dramatic induction of hyaluronan synthesis and prostaglandin endoperoxide H synthase-2 expression - Insights into potential pathogenic mechanisms of thyroid-associated ophthalmopathy [J].
Cao, HJ ;
Wang, HS ;
Zhang, Y ;
Lin, HY ;
Phipps, RP ;
Smith, TJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (45) :29615-29625
[10]   Interferon-α-related thyroid disease:: Pathophysiological, epidemiological, and clinical aspects [J].
Carella, C ;
Mazziotti, G ;
Amato, G ;
Braverman, LE ;
Roti, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (08) :3656-3661